Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma.

Authors:
Zhou Q; Xiong J; Gao Y; Yi R; Xu Y and 3 more

Journal:
Funct Integr Genomics

Publication Year: 2023

DOI:
10.1007/s10142-023-01245-3

PMCID:
PMC10590301

PMID:
37864709

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Funct Integr Genomics

Abbreviation: Funct Integr Genomics

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Molecular Biology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
DKC1 aggravates gastric cancer cell migration and invasion through up-regulating the expression of …
Chen H; Wu Y; Jiang Y and 2 more (2024) - Transparency Score: 2/6
Downregulation of lncRNA CDKN2B-AS1 attenuates inflammatory response in mice with allergic rhinitis…
Deng B; Zhao Y; Liu J. (2024) - Transparency Score: 3/6
ETV7 promotes colorectal cancer progression through upregulation of IFIT3.
Chai B; Li Y; Guo Y and 4 more (2024) - Transparency Score: 3/6
LINC00942 inhibits ferroptosis and induces the immunosuppression of regulatory T cells by recruitin…
Jin D; Hui Y; Liu D and 5 more (2024) - Transparency Score: 3/6
PCDH8 is a novel prognostic biomarker in thyroid cancer and promotes cell proliferation and viabili…
Yang R; Yang N; Yin P and 7 more (2024) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."

Evidence found in paper:

"Funding Hunan Provincial Natural Science Foundation (Provincial and Municipal Joint Fund) (#2022JJ50105) provided funding and grant its approval for the present research."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025